ZoomMed inc.
TSX VENTURE : ZMD

ZoomMed inc.

November 19, 2007 10:17 ET

ZoomMed Reaches 1,000 Physician Mark on its ZRx Prescriber

BROSSARD, QUEBEC--(Marketwire - Nov. 19, 2007) - ZoomMed inc. (TSX VENTURE:ZMD) is proud to announce a new milestone: 1000 physicians are now using its ZRx Prescriber, a new e-prescription tool for physicians.

"We're very proud of the work that our teams have done to reach this major milestone," stated Yves Marmet President and CEO of ZoomMed inc. "The demand for our solution continues to grow in Quebec, in Ontario and across Canada. We're filling a genuine need in the prescription industry by enabling medical workers to have access to clear and legible prescriptions," added Marmet.

About the distribution and integration of the ZRx Prescriber

The ZRx Prescriber has two main distribution routes: it can be directly distributed to Quebec and Ontario physicians by ZoomMed's teams, or it can be distributed by third parties, who must integrate the ZRx Prescriber to their existing electronic medical solutions. To date, there are no national exclusivity agreements for the direct distribution of the ZRx Prescriber, whose distribution rights are solely owned by ZoomMed.

About ZoomMed and the ZRx Prescriber

The ZRx Prescriber is a Web application that runs on a pocket computer or PC. The tool is used by physicians to fill out prescriptions and make them available to pharmacists, who can view them online via unique barcodes and confirm them using the physician's signed copy. Every year, Canadian prescription errors (illegible handwriting, incorrect dosage, drug interactions) lead to 700 fatalities and 150,000 hospitalizations, representing $600 million in healthcare costs.

The ZRx Prescriber also gives physicians access to a portable source of medical information generated by the pharmaceutical companies and private or public organizations that use this revolutionary new communication tool. Thanks to the ZRx Prescriber, thousands of Canadian physicians can now have access to vital information such as clinical studies, scientific discoveries, new product launches, medical training information and major medical alerts.

FOR FURTHER INFORMATION ON ZOOMMED, or for distribution and integration information on the ZRx Prescriber for your solution, contact us at the address below. You can also visit www.zoommed.com.

The TSX Venture Exchange does not assume any responsibility for the adequacy or accuracy of this press release.

Contact Information